Pfizer's COVID pill Paxlovid gains full FDA approval

Chia sẻ
(VOVWORLD) - The US Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment, Paxlovid, clearing the way for the drugmaker to sell the drug at market rates once US government supplies dwindle. 
Pfizer's COVID pill Paxlovid gains full FDA approval - ảnh 1  (Photo: Reuters) 

US officials have said they plan to work through much of the inventory of Paxlovid bought from Pfizer, which is available for free at pharmacies around the country, before moving to a normal commercial market for the drug. 

Pfizer has sold the US government nearly 24 million courses of Paxlovid at around 530 USD a course. It is not clear yet what the commercial price will be for the drug. 

Feedback